Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of MYO7A mRNA | increases expression | 19933214
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of MYO7A mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MYO7A mRNA | affects expression | 16483693
|
D001194 |
Asbestos |
Asbestos affects the expression of MYO7A mRNA | affects expression | 17297452
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of MYO7A mRNA | increases expression | 14729362
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of MYO7A mRNA | increases expression | 17606305
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of MYO7A gene | increases mutagenesis | 15965244
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in decreased expression of MYO7A mRNA | decreases expression | 20713471
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of MYO7A mRNA | decreases expression | 17426115
|
C020806 |
tetrabromobisphenol A |
tetrabromobisphenol A affects the expression of MYO7A mRNA | affects expression | 18976794
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MYO7A mRNA | increases expression | 19933214
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of MYO7A protein | increases expression | 17331193
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.71 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
7.46 | 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
7.46 | 6695378 10545420 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.42 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.42 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.70 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.42 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.42 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.29 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.37 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Asbestos |
7.52 | 18795166 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
7.52 | 11922910 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.53 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.93 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.93 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.93 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.98 | 14991843 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.39 | 16651633 18412241 15144691 16357521 16436596 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
1.92 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.92 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.92 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.74 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
8.63 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.63 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.33 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.05 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.05 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.32 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18850075 16120746 18670907 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.15 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
7.53 | 16003739 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
7.53 | 16192471 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
6.16 | 17160924 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.74 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.01 | 17110522 16105132 17333356 11677210 15861022 17681005 16919318 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.01 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.33 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.90 | 12621046 8697196 16354765 15340226 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.90 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.84 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.48 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.48 | 17551590 9142499 16925845 8800419 10589399 14991402 9211117 9664655 9125849 9224671 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.15 | 18551238 |
OMIM:601317 |
DEAFNESS, AUTOSOMAL DOMINANT 11 |
marker/mechanism |
|
| |
OMIM:600060 |
DEAFNESS, AUTOSOMAL RECESSIVE 2 |
marker/mechanism |
|
| |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
3.79 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.79 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
6.16 | 18357618 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.90 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.90 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.53 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.53 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.31 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.18 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.11 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.11 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.91 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.91 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
5.09 | 10962813 14633661 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.09 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.09 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
7.65 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.65 | 17312396 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.53 | 16651633 16357521 18412241 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.26 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.33 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.72 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.72 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.60 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.73 | 16221962 19176532 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.73 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 16959395 15340226 16354765 18606429 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.30 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.71 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.94 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.56 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.91 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.70 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.90 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.30 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.30 | 17551590 15992940 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.02 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
8.02 | 17379185 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.82 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.81 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.09 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.22 | 17217047 19035177 17107899 17649720 17368321 17506722 16935935 17294898 17301526 9834237 15748426 16891316 16331271 17361223 17339181 17712046 16140955 16788101 16766008 16823087 19225113 19642359 19075265 19029980 12679006 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.38 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.46 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.46 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.46 | 16248980 18397230 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.37 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.37 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
6.22 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.22 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Asbestos |
5.07 | 12111688 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
5.07 | 17703301 16019985 16271038 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
5.07 | 20512841 7750092 6695378 16337739 11893704 9230183 17909032 20970405 21163286 1399818 10545420 16271038 15390079 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
5.07 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
4.02 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
5.19 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
3.58 | 18041768 10767621 10838139 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.82 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.95 | 16752155 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
6.16 | 17943659 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.56 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos |
4.12 | 18709470 16564556 18310086 16319530 16919927 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.14 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.18 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.01 | 18551238 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.08 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.08 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.54 | 16707424 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.94 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.94 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.12 | 9142499 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.57 | 16651423 16003739 17160924 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.53 | 16049721 12819281 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
6.16 | 17160924 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.37 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.99 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.50 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.34 | 11222880 11399792 11118676 11896295 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.72 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 15861022 16919318 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.95 | 16723453 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.22 | 16283617 16116481 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.60 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.71 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.71 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.71 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
5.31 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.11 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.89 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.29 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.32 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.47 | 10091137 |
MESH:D052245 |
Usher Syndromes |
marker/mechanism |
|
| 15965244 |
OMIM:276900 |
USHER SYNDROME, TYPE I |
marker/mechanism |
|
| |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.78 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.78 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 15869587 14671159 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.18 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.07 | 16287080 |